Ambu
Ambu A/S, commonly referred to as Ambu, is a leading global provider of innovative medical devices headquartered in Denmark (DK). Founded in 1937, the company has established a strong presence in the healthcare industry, particularly in the fields of anaesthesia, patient monitoring, and emergency care. Ambu is renowned for its unique single-use endoscopy solutions and advanced airway management products, which enhance patient safety and streamline clinical workflows. With a commitment to quality and innovation, Ambu has achieved significant milestones, including the launch of its groundbreaking Ambu® aScope™. Today, Ambu operates in key markets across Europe, North America, and Asia, solidifying its position as a trusted partner in the medical community. The company’s dedication to improving patient outcomes and its robust product portfolio have earned it a notable reputation in the healthcare sector.
DitchCarbon Score
How does Ambu's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ambu's score of 67 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ambu's reported carbon emissions
In 2024, Ambu A/S reported total greenhouse gas emissions of approximately 209,157,000 kg CO2e. This figure includes 3,369,000 kg CO2e from Scope 1 emissions, 15,400,000 kg CO2e from Scope 2 emissions (market-based), and a significant 190,388,000 kg CO2e from Scope 3 emissions. The total emissions for 2023 were about 160,923,000 kg CO2e, indicating a rise in emissions year-on-year. Ambu has set ambitious climate commitments, aiming for a 75% reduction in absolute Scope 1 and Scope 2 GHG emissions by FY2030, using FY2021 as the baseline. Additionally, the company has pledged that 82% of its suppliers, based on emissions from purchased goods and services, will have science-based targets by FY2027. Furthermore, Ambu is committed to achieving net-zero emissions across all scopes by 2045. These targets align with the Science Based Targets initiative (SBTi) and reflect Ambu's commitment to sustainable practices within the healthcare equipment and supplies sector. The company is actively working towards these goals, demonstrating a proactive approach to reducing its carbon footprint and addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,337,000 | 000,000 | 000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,886,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ambu is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
